Supervisory Board

Klaas de Boer, Chairman, Managing Partner of Entrepreneurs Fund Management LLP, London, UK. He has spent the last 10 years working with entrepreneurial (technology) companies in Europe, Israel and the US in the areas of finance, strategy and business development. Previously he established and managed a corporate venturing team at Vanenburg Group, and worked as a strategy consultant with McKinsey & Co.

Clemens Doppler, PhD, Board Member, is Managing Partner of HeidelbergCapital Asset Management GmbH.

Thomas Lander, MD, Board Member, is an independent R&D consultant to the biotech industry. He is a physician with board certification in internal medicine and diabetology. Dr Lander has spent 23 years in the pharmaceutical and biotech industry where he had senior management positions with major international companies including Boehringer Ingelheim, NovoNordisk, BMS, GSK and Merck. Most recently, he was managing director of CureVac, Tuebingen.